Credit Suisse’s Aurinia Pharmaceuticals AUPH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q1
$1.1M Hold
219,468
﹤0.01% 2202
2023
Q4
$1.97M Buy
219,468
+55,597
+34% +$500K ﹤0.01% 1882
2023
Q3
$1.27M Buy
163,871
+4,081
+3% +$31.7K ﹤0.01% 2128
2023
Q2
$1.55M Buy
159,790
+34,944
+28% +$338K ﹤0.01% 2082
2023
Q1
$1.37M Buy
124,846
+8,580
+7% +$94K ﹤0.01% 2101
2022
Q4
$502K Sell
116,266
-24,823
-18% -$107K ﹤0.01% 2753
2022
Q3
$1.06M Buy
141,089
+46,328
+49% +$348K ﹤0.01% 2271
2022
Q2
$953K Sell
94,761
-9,338
-9% -$93.9K ﹤0.01% 2408
2022
Q1
$1.29M Sell
104,099
-177,048
-63% -$2.19M ﹤0.01% 2355
2021
Q4
$6.43M Buy
281,147
+199,200
+243% +$4.56M ﹤0.01% 1352
2021
Q3
$1.81M Sell
81,947
-16,028
-16% -$355K ﹤0.01% 2208
2021
Q2
$1.27M Sell
97,975
-68,108
-41% -$882K ﹤0.01% 2468
2021
Q1
$2.16M Buy
166,083
+51,105
+44% +$664K ﹤0.01% 2091
2020
Q4
$1.59M Buy
114,978
+17,892
+18% +$248K ﹤0.01% 2278
2020
Q3
$1.43M Buy
97,086
+31,059
+47% +$458K ﹤0.01% 2036
2020
Q2
$1.07M Sell
66,027
-4,065
-6% -$66.1K ﹤0.01% 2278
2020
Q1
$1.02M Buy
70,092
+20,734
+42% +$301K ﹤0.01% 2093
2019
Q4
$1M Buy
49,358
+26,552
+116% +$538K ﹤0.01% 2500
2019
Q3
$121K Sell
22,806
-1,497
-6% -$7.94K ﹤0.01% 3273
2019
Q2
$160K Buy
24,303
+4,194
+21% +$27.6K ﹤0.01% 3245
2019
Q1
$130K Buy
20,109
+2,894
+17% +$18.7K ﹤0.01% 3231
2018
Q4
$118K Sell
17,215
-1,812
-10% -$12.4K ﹤0.01% 3213
2018
Q3
$127K Sell
19,027
-3,851
-17% -$25.7K ﹤0.01% 3227
2018
Q2
$128K Sell
22,878
-5,422
-19% -$30.3K ﹤0.01% 3348
2018
Q1
$147K Buy
28,300
+9,021
+47% +$46.9K ﹤0.01% 3322
2017
Q4
$87K Buy
+19,279
New +$87K ﹤0.01% 3352